Dr Tom Forbes
Dr Tom Forbes
Contact
Available for student supervision
Tom is a Consultant Paediatric Nephrologist at the Royal Children's Hospital. He completed his undergraduate training with Monash University in 2005. He trained in paediatric nephrology at Birmingham Children’s Hospital and Nottingham University Hospital Queen’s Medical Centre in the UK where he developed an interest in rare, inherited, paediatric renal diseases returning to Melbourne in 2013 and completed a paediatric nephrology fellowship at the Royal Children's Hospital. He became a Fellow of the Royal Australasian College of Physicians in 2015. He is currently the Clinical Lead for Education and Renal Biopsy for the RCH Department of Nephrology.
He entered laboratory research in 2016 with Prof Melissa Little's Kidney Regeneration group, completing a PhD documenting the capabilities and limitations of kidney organoids as functional genomic disease models in 2020. Tom has been awarded a Clinician Scientist Fellowship by MCRI to continue his research in kidney organoids and genetic kidney disease in 2020. He is Principle Investigator for clinical trials investigation novel therapies for primary hyperoxaluria. He is a named investigator on NHMRC and MRFF Funded grants investigating the genomic testing in kidney disease and disease modelling with iPSC derived kidney organoids. He is a Steering Committee member of KidGen and the MCRI Kidney Research Flagship.
He entered laboratory research in 2016 with Prof Melissa Little's Kidney Regeneration group, completing a PhD documenting the capabilities and limitations of kidney organoids as functional genomic disease models in 2020. Tom has been awarded a Clinician Scientist Fellowship by MCRI to continue his research in kidney organoids and genetic kidney disease in 2020. He is Principle Investigator for clinical trials investigation novel therapies for primary hyperoxaluria. He is a named investigator on NHMRC and MRFF Funded grants investigating the genomic testing in kidney disease and disease modelling with iPSC derived kidney organoids. He is a Steering Committee member of KidGen and the MCRI Kidney Research Flagship.
Tom is a Consultant Paediatric Nephrologist at the Royal Children's Hospital. He completed his undergraduate training with Monash University in 2005. He trained in paediatric nephrology at Birmingham Children’s Hospital and Nottingham University...
Tom is a Consultant Paediatric Nephrologist at the Royal Children's Hospital. He completed his undergraduate training with Monash University in 2005. He trained in paediatric nephrology at Birmingham Children’s Hospital and Nottingham University Hospital Queen’s Medical Centre in the UK where he developed an interest in rare, inherited, paediatric renal diseases returning to Melbourne in 2013 and completed a paediatric nephrology fellowship at the Royal Children's Hospital. He became a Fellow of the Royal Australasian College of Physicians in 2015. He is currently the Clinical Lead for Education and Renal Biopsy for the RCH Department of Nephrology.
He entered laboratory research in 2016 with Prof Melissa Little's Kidney Regeneration group, completing a PhD documenting the capabilities and limitations of kidney organoids as functional genomic disease models in 2020. Tom has been awarded a Clinician Scientist Fellowship by MCRI to continue his research in kidney organoids and genetic kidney disease in 2020. He is Principle Investigator for clinical trials investigation novel therapies for primary hyperoxaluria. He is a named investigator on NHMRC and MRFF Funded grants investigating the genomic testing in kidney disease and disease modelling with iPSC derived kidney organoids. He is a Steering Committee member of KidGen and the MCRI Kidney Research Flagship.
He entered laboratory research in 2016 with Prof Melissa Little's Kidney Regeneration group, completing a PhD documenting the capabilities and limitations of kidney organoids as functional genomic disease models in 2020. Tom has been awarded a Clinician Scientist Fellowship by MCRI to continue his research in kidney organoids and genetic kidney disease in 2020. He is Principle Investigator for clinical trials investigation novel therapies for primary hyperoxaluria. He is a named investigator on NHMRC and MRFF Funded grants investigating the genomic testing in kidney disease and disease modelling with iPSC derived kidney organoids. He is a Steering Committee member of KidGen and the MCRI Kidney Research Flagship.
Top Publications
- Crofts, VL, Forbes, T, Grover, SR. Chronic, severe abdominal pain in a girl with a renal anomaly: Answers. Pediatric Nephrology 38(12) : 3985 -3988 2023 view publication
- Crofts, VL, Forbes, T, Grover, SR. Chronic, severe abdominal pain in a girl with a renal anomaly: Questions. Pediatric Nephrology 38(12) : 3983 -3983 2023 view publication
- Baum, MA, Langman, C, Cochat, P, Lieske, JC, Moochhala, SH, Hamamoto, S, Satoh, H, Mourani, C, Ariceta, G, Torres, A, et al. PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2. Kidney International 103(1) : 207 -217 2023 view publication
- Dorison, A, Ghobrial, I, Graham, A, Peiris, T, Forbes, TA, See, M, Das, M, Saleem, MA, Quinlan, C, Lawlor, KT, et al. Kidney Organoids Generated Using an Allelic Series of NPHS2 Point Variants Reveal Distinct Intracellular Podocin Mistrafficking. Journal of the American Society of Nephrology 34(1) : 88 -109 2023 view publication
- Dorison, A, Forbes, TA, Little, MH. What can we learn from kidney organoids?. Kidney International 102(5) : 1013 -1029 2022 view publication
Page 1 of 5
Career information
Share //
